We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$155B
AUM Growth
+$5.59B
Cap. Flow
-$1.23B
Cap. Flow %
-0.8%
Top 10 Hldgs %
15.41%
Holding
3,924
New
119
Increased
2,245
Reduced
1,145
Closed
87

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$128M
2
AAL icon
American Airlines Group
AAL
+$99.2M
3
NAVI icon
Navient
NAVI
+$54.9M
4
ESS icon
Essex Property Trust
ESS
+$53.7M
5
AVGO icon
Broadcom
AVGO
+$47.2M

Sector Composition

Rank Sector Weight
1 Financials 14.61%
2 Technology 13.94%
3 Healthcare 13.29%
4 Industrials 10.85%
5 Energy 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOLT
2876
DELISTED
BOLT TECHNOLOGY CORPORATION
BOLT
$806K ﹤0.01%
43,965
+958
+2% +$16.9K
SPRT
2877
DELISTED
support.com, Inc.
SPRT
$804K ﹤0.01%
98,982
-10,649
-10% -$76.2K
ATNM icon
2878
Actinium Pharmaceuticals
ATNM
$24.2M
$803K ﹤0.01%
+3,709
New +$1.24M
AMBA icon
2879
Ambarella
AMBA
$3.6B
$801K ﹤0.01%
25,711
+8,310
+48% +$220K
VRNS icon
2880
Varonis Systems
VRNS
$4.87B
$798K ﹤0.01%
82,620
+2,235
+3% +$19K
VTNR
2881
DELISTED
Vertex Energy, Inc
VTNR
$798K ﹤0.01%
82,197
+68,535
+502% +$587K
NSTG
2882
DELISTED
NanoString Technologies, Inc.
NSTG
$797K ﹤0.01%
53,372
+7,288
+16% +$115K
E icon
2883
ENI
E
$79.4B
$796K ﹤0.01%
14,517
+2,618
+22% +$135K
LSTA icon
2884
Lisata Therapeutics
LSTA
$9.82M
$794K ﹤0.01%
813
+204
+33% +$198K
SFL icon
2885
SFL Corp
SFL
$1.58B
$793K ﹤0.01%
42,692
+4,660
+12% +$83.6K
AMNB
2886
DELISTED
American National Bankshares Inc
AMNB
$792K ﹤0.01%
36,459
+7,441
+26% +$163K
RST
2887
DELISTED
ROSETTA STONE INC
RST
$791K ﹤0.01%
81,387
+15,578
+24% +$163K
MSL
2888
DELISTED
Midsouth Bancorp, Inc.
MSL
$791K ﹤0.01%
39,782
+5,467
+16% +$98.3K
BBVA icon
2889
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
$789K ﹤0.01%
65,011
+6,146
+10% +$73.7K
NRIM icon
2890
Northrim BanCorp
NRIM
$588M
$788K ﹤0.01%
123,320
+39,540
+47% +$244K
PLPC icon
2891
Preformed Line Products
PLPC
$2.26B
$785K ﹤0.01%
14,598
-11
-0.1% -$628
RDS.B
2892
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$785K ﹤0.01%
9,026
+4,814
+114% +$400K
ADUS icon
2893
Addus HomeCare
ADUS
$2.23B
$784K ﹤0.01%
34,892
-9,116
-21% -$205K
JOUT icon
2894
Johnson Outdoors
JOUT
$501M
$784K ﹤0.01%
30,391
+2,509
+9% +$59.7K
GYRE icon
2895
Gyre Therapeutics
GYRE
$713M
$783K ﹤0.01%
221
-25
-10% -$81.6K
WINT
2896
DELISTED
Windtree Therapeutics Inc
WINT
$780K ﹤0.01%
31,331
+3,224
+11% +$82.4K
GSOL
2897
DELISTED
Global Sources Ltd
GSOL
$779K ﹤0.01%
94,090
-18,287
-16% -$154K
MCRI icon
2898
Monarch Casino & Resort
MCRI
$2.17B
$777K ﹤0.01%
51,373
-8,077
-14% -$131K
ALDR
2899
DELISTED
Alder Biopharmaceuticals
ALDR
$777K ﹤0.01%
+38,748
New +$546K
DRNA
2900
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$775K ﹤0.01%
34,380
+278
+0.8% +$5.04K

Similar funds

Geode Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Geode Capital Management held 3,924 positions worth $155B, up 3.7% from $149B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Geode Capital Management's Q2 2014 filing shows 119 new, 2,245 increased, 1,145 reduced and 87 closed positions. Its largest new stake was Navient: 3,319,977 shares worth $58.8M. The largest sale was Apple, an estimated $219M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

  • Geode Capital Management's largest Q2 2014 buy was Navient: 3,319,977 shares worth $58.8M.
  • Geode Capital Management added most to Allergan plc in Q2 2014, an estimated $128M increase.
  • Geode Capital Management's biggest Q2 2014 reduction was Apple, cutting an estimated $219M.
  • Geode Capital Management fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $103M.
  • Geode Capital Management's ten largest holdings make up 15% of its $155B portfolio in Q2 2014.
  • Geode Capital Management opened 119 new positions and closed 87 in Q2 2014.
  • Geode Capital Management's portfolio value rose 3.7% quarter-over-quarter to $155B.

Based on Geode Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.